Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer.
2014 ◽
Vol 32
(15_suppl)
◽
pp. 598-598
Keyword(s):
Phase I
◽
2014 ◽
Vol 146
(1)
◽
pp. 145-152
◽
2005 ◽
Vol 63
(4)
◽
pp. 1276
◽
2010 ◽
Vol 26
(5)
◽
pp. 514-521
◽
2014 ◽
Vol 149
(1)
◽
pp. 163-169
◽